COVID-19 Safety Protocols

Updated 4/29/2022

Updates to these protocols are contingent on changes during the pandemic. SourceAmerica has put in place preventative measures to reduce the spread of COVID-19 to ensure participants can take part safely in the Xforce 2022 National Conference ("Conference"), which are outlined below. However, because an inherent risk of exposure to COVID-19 exists in any place where people gather, SourceAmerica makes no guarantee that participants will not become infected with COVID-19.

Vaccinations

  • All participants are encouraged to be fully vaccinated unless they have an objection to the vaccine for any reason of personal conscience, based on a religious belief, or for medical reasons, including prior recovery from COVID-19.
    • A person is considered fully vaccinated for COVID-19 two weeks after they have received the second dose in a two-dose series, such as Pfizer or Moderna, or two weeks after they have received a single-dose vaccine, such as Johnson & Johnson’s Janssen vaccine. Final doses of your vaccination would need to be completed no later than Monday, May 9, to be considered fully vaccinated for the Conference.
    • If the definition of fully vaccinated changes to include a booster, SourceAmerica will update these COVID-19 Safety Protocols and inform all registered participants.
  • SourceAmerica is partnering with Cvent Health Check Powered by ID.me to collect proof of vaccination. Participants are encouraged to follow the instructions in the registration email to upload their proof of vaccination to the secure Health Check Verification website prior to the first day of the Conference. 

Masking and Physical Distancing

  • Masking and physical distancing is optional for participants.
  • Hotel staff are required to wear masks during banquet services.
  • Meeting rooms will be set up in compliance with any distancing and capacity guidelines in Texas.

Hand Hygiene and Personal Protective Equipment ("PPE")

  • While participating in the Conference, consistent with the Centers for Disease Control and Prevention ("CDC") guidelines, participants must practice hand hygiene.
  • Participants should cover coughs and sneezes with bent elbow or tissues, and wash hands frequently.
  • Hand sanitizer stations are located throughout the hotel.
  • PPE and personal hand sanitizer will be provided to all participants in their Conference welcome bags.
  • Additional PPE will be available, upon request, at the Conference registration desk.

Reporting and Self-Monitoring

  • Participants are required to complete an initial Health Questionnaire upon their arrival on Sunday, May 22 or Monday, May 23 at the registration desk.
  • Participants should not attend the Conference if they have any COVID-19 symptoms, including sudden loss of taste or smell and/or fever. Participants should get tested for COVID-19.
  • Participants should not attend the Conference if they have been recently diagnosed with COVID-19, have recently had direct contact with an individual diagnosed with or suspected to have COVID-19, or are displaying symptoms commonly associated with COVID-19. The CDC recommends:
    • If you were exposed to someone with COVID-19 you should quarantine for 5 days. If you do not develop symptoms, get tested at least 5 days after you last had close contact with someone with COVID-19 and make sure you test results are negative prior to traveling. If you do not get tested, you should delay travel until 10 days after your last close contact with a person with COVID-19.
    • If you tested positive for COVID-19 or have symptoms, you should isolate for 5 days. After you end isolation, you should delay travel until 10 days after symptoms onset or the date of specimen collection for a positive vial test results if asymptomatic. 

      For more CDC guidance and recommendations regarding quarantine and isolation, participants should review the latest CDC guidelines. 
  • Participants who are sick, have any symptoms of COVID-19, or test positive for COVID-19 during the Conference, must report to the hotel and Jessica Hardy, Senior Corporate Council at 571-274-2024. If a COVID-19 case is detected while onsite, the guest must quarantine in place in their hotel room or leave the hotel. Once reported, the hotel will initiate a contact tracing investigation. The hotel will notify SourceAmerica whether the guest is a Conference participant or if any participant was in contact with the guest. 
  • Participants must report to the hotel and Jessica Hardy if they test positive for COVID-19 within 10 days of attending the Conference.

Hotel Safety Standards

  • The Hyatt Regency Dallas is fully Global Biorisk Advisory Council ("GBAC") rated for cleanliness and procedures—the highest level possible. In addition, the hotel has a dedicated Cleanliness Team with enhanced electrostatic disinfectant tools.
  • The Hyatt Regency Dallas has implemented a vast range of other health and safety measures which can be viewed here.